Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07195175 · ClinicalTrials.gov registry record · Phase 1
Study of MAR002 in Healthy Men
A Phase 1 study of Acromegaly, sponsored by Marea Therapeutics.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 45
- Enrollment target
- 1
- Study location
NCT07195175 is a Phase 1 study of Acromegaly that is actively recruiting participants, run by Marea Therapeutics. The registered enrollment target is 45 participants, below the 98-participant average among 13 other Acromegaly trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07195175, a Phase 1 study of Acromegaly, is actively recruiting participants, sponsored by Marea Therapeutics.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
Evaluate the safety and tolerability of subcutaneous (SC) administration of MAR002 in healthy men
Conditions Studied
Interventions
- DRUG Placebo
- DRUG MAR002
Study Locations (1)
Arizona
- Marea Site - Tempe
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2025-08-11 |
| Est. Completion | 2026-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07195175
The ClinicalTrials.gov registry entry for NCT07195175 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 98-participant average among 13 other Acromegaly trials with a reported enrollment target (54% lower). The listed sponsor is Marea Therapeutics, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acromegaly appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT07195175 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT07195175 about?
NCT07195175 is a clinical study titled "Study of MAR002 in Healthy Men". Evaluate the safety and tolerability of subcutaneous (SC) administration of MAR002 in healthy men
What is the current status of trial NCT07195175?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 45 participants. The study started on 2025-08-11. Estimated completion is 2026-07.
What conditions does trial NCT07195175 study?
This clinical trial studies the following conditions: Acromegaly.
What interventions are being tested in trial NCT07195175?
The interventions under investigation include: Placebo (DRUG), MAR002 (DRUG).
Who is sponsoring clinical trial NCT07195175?
This trial is sponsored by Marea Therapeutics, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07195175 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acromegaly
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
ALXN2420 Versus Placebo in Combination With Somatostatin Analogs in Participants With Acromegaly
RECRUITING · Phase 2
-
A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs
RECRUITING · Phase 3
-
Diet in the Management of Acromegaly
RECRUITING · NA
-
Peri-operative Dynamics of the Growth Hormone Axis in Subjects With Acromegaly
ACTIVE NOT RECRUITING
-
A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (PATHFNDR-2)
ACTIVE NOT RECRUITING · Phase 3
-
A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly
ACTIVE NOT RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.